Table 2. Details of prior therapy (Phase II patients).
| Patients, N=54 | % | |
|---|---|---|
|
Type of prior therapy | ||
| Surgery for primary tumour | 47 | 87.0 |
| Surgery for metastases | 17 | 31.5 |
| Adjuvant chemotherapy | 24 | 44.4 |
| Palliative chemotherapy | 54 | 100.0 |
| 1 Line | 7 | 12.9 |
| 2 Lines | 11 | 20.4 |
| 3 Lines | 15 | 27.8 |
| ⩾ 4 Lines | 21 | 38.9 |
| Radiotherapy |
25 |
46.3 |
|
Failure of previous medication | ||
| 5-FU | 54 | 100.0 |
| Irinotecan | 54 | 100.0 |
| Oxaliplatin | 52 | 96.3 |
| Bevacizumab | 49 | 90.7 |
| Cetuximab | 9 | 16.7 |